shortagewatch

Home / Sensory organs / Bromfenac

ATC S01BC11 · Antiinflammatory Agents, Non-Steroids

Bromfenac shortage

As of 2 Nov 2026, Bromfenac has a reported shortage in 3 of the 15 countries we track (Canada, France, Norway), covering 3 products from 2 companies.

Countries3/15
Products3packs or presentations
Companies21 listed
Short since8 Jul 202516 months ago
Earliest return31 Jan 2027company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFrance1 product shortItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorway1 product shortSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage

Timeline

CanadaFranceNorway
20262027APO-BROMFENAC (3 ML)APO-BROMFENAC (3 ML)Yellox 0,9 mg/ml, collyre en solutionYellox 0,9 mg/ml, collyre en solutionYellox 0,9 mg/ml øyedråper, oppløsning, 5 mlYellox 0,9 mg/ml øyedråper, oppløsning, 5 ml flasketoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Apotex1Bausch Health1 BHC

Listed: Bausch Health BHC · NYSE / TSX

Compared with similar medicines

ATC group S01BC · Antiinflammatory Agents, Non-Steroids
Diclofenac8/15Bromfenac3/15Indometacin1/15Ketorolac1/15Nepafenac1/15

Affected products

CountryProductCompanySinceExpected backReason
CAAPO-BROMFENAC (3 ML)APOTEX INC8 Jul 202525 Jun 2027Manufacturing problem
Disruption of the manufacture of the drug
FRYellox 0,9 mg/ml, collyre en solution6 Aug 2026not givenNot stated
NOYellox 0,9 mg/ml øyedråper, oppløsning, 5 ml flaskeBAUSCH + LOMB IRELAND LIMITED22 Oct 202631 Jan 2027Increased demand
Uventet økt etterspørsel

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.